Sign in

You're signed outSign in or to get full access.

Olga Castells

Director at Trailblazer Merger Corp I
Board

About Olga Castells

Olga Castells is an independent director of Trailblazer Merger Corporation I (TBMC). She is a CPA (Florida) with a BS in Accounting (cum laude) and an MS in Taxation from the University of Miami, and has held senior tax leadership roles in multinational environments, including Oracle and PwC; since November 2024, she has been a Managing Director at Socorro Partners focusing on Tax M&A and middle-market tax consulting . TBMC’s filings identify Castells as one of the board’s independent directors under Nasdaq rules .

Past Roles

OrganizationRoleTenureCommittees/Impact
Socorro PartnersManaging Director (Tax M&A)Since Nov 2024Tax advisory leadership for middle-market clients
Oracle CorporationTax Senior DirectorSince 2010Led audit controversy matters in Canada & Latin America (~$3B region), managed 100+ audits across 9 countries
PricewaterhouseCoopers (PwC)Various roles~5 years prior to OracleInternational tax planning for large multinationals across multiple regions and industries

External Roles

OrganizationRoleTenureNotes
None disclosedNo other public company directorships disclosed for Castells

Board Governance

  • Independence: TBMC states Barak Avitbul, Olga Castells, and Patrick Donovan are independent directors under Nasdaq standards .
  • Audit Committee: Members are Avitbul, Castells, and Donovan; Donovan is Chair. All are independent; committee duties include auditor oversight, pre-approval of services, related-party transaction reviews, and compliance matters .
  • Compensation Committee: Members are Avitbul, Castells, and Donovan; Avitbul is Chair. Duties include executive compensation policies, incentive plan oversight, disclosure compliance, and director remuneration recommendations (post-business combination) .
  • Director Nominations: TBMC has no standing nominating committee; independent directors (Avitbul, Castells, Donovan) participate in nominating recommendations under Nasdaq Rule 5605(e) .
  • Independent Sessions: TBMC notes independent directors will have regularly scheduled meetings with only independent directors present .

Fixed Compensation

ComponentAmount/PolicyNotes
Annual cash retainerNoneTBMC states no compensation of any kind is paid to directors prior to consummation of an initial business combination; only out-of-pocket reimbursements are allowed .
Committee membership feesNoneNo director fees pre-business combination .
Committee chair feesNoneNo director fees pre-business combination .
Meeting feesNoneNo director fees pre-business combination .

Performance Compensation

Metric/InstrumentDisclosureVesting/Terms
Equity awards (RSUs/PSUs)None before business combinationTBMC does not grant or pay equity compensation to directors before the initial business combination .
OptionsNone before business combinationNo options awarded to directors prior to business combination .
Cash bonusNone before business combinationNo cash bonuses to directors prior to business combination .
Performance metrics (TSR/EBITDA/ESG)Not applicable pre-business combinationCompensation policies will be determined by the post-combination board if applicable .

Other Directorships & Interlocks

ItemDisclosure
Other public company boardsNone disclosed for Castells
Compensation committee interlocksTBMC discloses none among its officers over the past year; compensation oversight remains with independent directors .

Expertise & Qualifications

  • Technical expertise: International tax planning, audit controversy management, M&A tax due diligence; CPA licensed in Florida .
  • Industry experience: Multinational operations across Canada, Latin America, Europe, Asia, and the Caribbean; sectors include consumer products, retail, manufacturing, franchise services, and power generation .
  • Governance credentials: Independent director; member of Audit and Compensation Committees; participates in director nominations under Nasdaq rules .

Equity Ownership

ItemValueAs-of Date
Total beneficial ownership (% of outstanding shares)Less than 1%Sept 2, 2025
Shares pledged as collateralNone disclosedSept 2, 2025
Ownership guidelinesNot disclosed
Vested vs unvested sharesNot disclosed

Governance Assessment

  • Signals supporting effectiveness:
    • Independent status and service on both Audit and Compensation Committees align with governance best practices; audit committee includes an SEC-defined “financial expert” (Donovan) and performs robust oversight (auditor independence, related-party reviews) .
    • Participation in director nominations by independent directors (including Castells) without a standing committee reflects compliance with Nasdaq Rule 5605(e) and keeps influence with independent directors .
  • Risk indicators and potential conflicts:
    • SPAC structure: The Sponsor beneficially owns ~47.11% of voting power (as of Sept 2, 2025), which can influence outcomes; TBMC explicitly discloses directors and officers have interests that may differ from stockholders regarding extension and business combination approvals .
    • Pre-combination compensation framework: No director compensation or equity grants prior to closing may limit traditional pay-for-performance alignment at the SPAC stage; only reimbursements are permitted .
    • Related-party safeguards exist but execution risk remains: Any related-party transactions require audit committee and independent director approval and must be on no less favorable terms than third parties; TBMC prohibits consummating a business combination with insider-affiliated entities without fairness opinions and independent director approval .
  • Attendance/engagement:
    • TBMC does not disclose director meeting attendance rates in recent proxy/10-K materials; independent director-only sessions are planned .

RED FLAGS

  • Concentrated sponsor control (~47.11% voting power) may diminish minority shareholder influence and raise concerns about board independence in extension votes .
  • Directors and officers have stated interests in extension proposals that can conflict with public stockholder preferences, per TBMC disclosures of potential conflicts .